3 Hawthorne AB, Logan RFA, Hawkey CJ, Foster PN, Axon AT, Swarbrick ET et al. Randomised controlled trial of azathioprine withdrawal in ulcerative colitis. Br& nbsp;Med J , 1992;305(6844):20-22

　　4 Sandborn WJ, Van Os EC, Zins BJ, Tremaine WJ, Mays DC, Lipsky JJ et al. An intravenous loading dose of azathioprine decreases the time to response in patients with Crohn＇s disease. Gastroenterology, 1995;109(6):1808-1817

　　5 Connel WR, Kamm MA, Dickson M, Balkwill AM, Ritchie JK, Lennard Jones et al. Long-term neoplasia risk after azathioprine treatment in inflammatory bowel disease. Lancet, 1994;343(8908):1249-1252

　　6 Feagan BG, McDonald JWD, Rochon J, Laupacis A, Fedorak RN, Kinnear D. Low-dose cyclosporine for the treatment of Crohn＇s disease. N Engl J Med, 1994;330(26):1846-1851

　　7 Jewell DP, Lennard-Jones JE, and the Cyclosporin Study Group of Great Britain and lreland. Oral cyclosporin for chronic active Crohn＇s disease. A multicentre controlled trial. Eur J Gastroenterol Hepatol, 1994;6(3):499-505

　　8 Stange EF, Modigliani R, Penna AS, Wood AJ, Feutren G, Smith PR. European trial of cyclosporin in chronic active Crohn＇s disease: a 12 month study. Gastroenterology, 1995;109(3):774-782

　　9 Brynskov J, Freund L, Rasmussen SN, Lauritsen K.&nbs p;Final report on a placebocontrolled, double-blind, randomized trial of cyclosporin treatment in active chronic Crohn＇s disease. Scand J Gastroenterol, 1991;26(7):689-695

　　10 Sandborn WJ. A critical review of cyclosporine therapy in inflammatory bowel disease. Inflamm Bowel Dis, 1995;1(1):48-63

　　11 Present DH, Lichtiger S. Efficacy of cyclosporine in treatment of fistula in Crohn＇s disease. Dig Dis Sci, 1994;39(2):374-380

　　12 Hanauer SB, Smith MB. Rapid closure of Crohn＇s disease fistulas with intravenous cyclosporine A. Am J Gastroenterol, 1993;88(5):646-649

　　13 Lichtiger S, Present DH, Kornbluth A, Gelernt I, Bauer J, Galler G. Cyclosporine in severe ulcerative colitis refractory to steroid therapy. N Engl J Med, 1994;330(26):1841-1845

　　14 Chamiot-Prieur C, Lemann M, Mesnard B. Treatment of refractory Crohn＇s diseasel (CD) with methotrexate (MTX). Gastroenterology, 1993;104(3):A680(abstract)

　　15 Baron TH, Truss CD, Elson CO. Low-dose oral methotrexate in refractory inflammatory bowel disease. Dig Dis Sci, 1993;38(10):1851-1856

　　16 Arora S, Katov WN, Cooley J. A double-bind randomized placebo-controlled  trial of methotrexate in Crohn＇s disease. Gastroenterology, 1992;102(3):A591(abstract)

　　17 Feagan BG, Rochon J, Fedorak RN, Irvine EJ, Wild G, Sutherland L. Methotrexate for the treatment of Crohn＇s disease. N Engl J Med, 1995;332(5):292-297

　　18 Kozarek RA, Patterson DJ, Gelfand MD. Long-term use of methotrexate in inflammatory bowel disease severe disease 3, drug therapy 2, seventh inning stretch. Gastroenterology, 1992;102(3):A646(abstract)

　　19 Kozarek RA. Review ariticle: immunosuppressive therapy for inflammatory bowel disease. Aliment Pharmacol Ther, 1993;7(2):117-123

　　20 Goodman TA, Polisson RP. Methotrexate: adverse reactions and major toxicities. Rheumatic Dis Clin North Am, 1994;20(2):513-528

　　21 Whiting-O＇keefe QE, Fye KH, Sack KD. Methotrexate and histologic hepatic abnormalities: a meta-analysis. Am J Med, 1991;90(6):711-716

　　22 Weinblatt ME. Methotrexate for chronic disease in adults. N Engl J Med, 1995;332(5):330-331

　　23 Scully CJ, Anderson CJ, Cannon GW. Long-term methotrexate therapy for rheumatoid arthritis. Semin Arthritis Rheum, 1991;20(5):317-331